Alota, Jhaydeil A.

HRN: 23-12-81  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
06/02/2023
06/08/2023
PO
7.5ml
Q12
UTI
Waiting Final Action 
06/02/2023
CEFUROXIME 750MG (VIAL)
06/02/2023
06/08/2023
IV
750mg
Q8hr
Urinary Tract Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: